Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Researchers have identified four new regions of the genome linked with an increase in susceptibility to chronic lymphocytic leukaemia (CLL). The findings suggest that this common type of blood cancer may develop partly as a result of faults in telomeres, sections of DNA that are vital to healthy cell division.
Scientists at The Institute of Cancer Research, London, analysed the genomes of 1,739 patients with CLL and 5,199 healthy adults. The study linked four single nucleotide polymorphisms (SNPs), small inherited differences in DNA, with susceptibility to CLL.
The research, published online in the journal Nature Genetics, was principally funded by blood cancer charity Leukaemia & Lymphoma Research, with additional support from Cancer Research UK and the Arbib Fund.
CLL is the most common form of leukaemia in western countries, with over 3,000 people diagnosed in the UK each year. It is a slowly progressing and currently incurable form of cancer that affects blood-producing cells in the bone marrow. Close relatives of CLL patients are at eight times higher risk of being diagnosed than the general population.
Study leader Richard Houlston, Professor of Molecular and Population Genetics at The Institute of Cancer Research, London, said: "We are starting to complete the picture of how CLL development is dictated by mutations in regions of the genome connected to specific aspects of DNA repair. These genetic factors explain a significant proportion of inherited cases of CLL."
The total number of risk variants for CLL identified is now 30, with the genetic factors newly identified by the study found around a set of genes responsible for the function of telomeres. Telomeres are sections of DNA that cap the end of chromosomes, preventing damage during cell division and the creation of mutated and eventually cancerous cells.
Professor Chris Bunce, Research Director at Leukaemia & Lymphoma Research, said: "These findings are very important - the identification of this cluster of so many risk variants around these neighbouring genes greatly deepens our understanding of how CLL develops. The challenge is now to use this information to improve treatments for this blood cancer, which remains incurable."
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia, Helen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, Martin J S Dyer, Amy Holroyd, Yufei Wang, Nicola J Sunter, Larry Mansouri, Gunnar Juliusson, Karin E Smedby, Göran Roos, Sandrine Jayne, Aneela Majid, Claire Dearden, Andrew G Hall, Tryfonia Mainou-Fowler, Graham H Jackson, Geoffrey Summerfield, Robert J Harris, Andrew R Pettitt, David J Allsup, James R Bailey, Guy Pratt, Chris Pepper, Chris Fegan, Nature Genetics (2013) doi:10.1038/ng.2843
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Lymphoma / Leukemia / Myeloma category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Leukaemia & Lymphoma Research. "New genetic links found to most common type of leukaemia." Medical News Today. MediLexicon, Intl., 3 Dec. 2013. Web.
20 Apr. 2014. <http://www.medicalnewstoday.com/releases/269572>
Leukaemia & Lymphoma Research. (2013, December 3). "New genetic links found to most common type of leukaemia." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269572.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.